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Several techniques exist for the assessment of cell prolifera-
tion in cell suspensions and tissues. These include counting of
mitotic figures; labelling with tritiated thymidine or
bromodeoxyuridine, and DNA flow cytometry. The latter is
a particularly versatile technique applicable to both fresh and
formalin fixed paraffin embedded tissue, and its use in the
investigation of tumour biology has increased enormously
over the past 10 years. DNA ploidy and the level of cell
proliferation have repeatedly been shown to provide prognos-
tic information in a variety of tumours (Merkel & McGuire,
1990) making this an attractive tool for both clinicians and
pathologists to employ. Despite the popularity of the tech-
nique, however, a number of problems exist which have been
largely ignored in the non-specialist scientific literature. It is
important to take these into account when comparing flow
cytometric studies of similar tumour systems, and it is in
order to draw attention to this that we are communicating
our own experience in assessing cell proliferation.
Whilst the definition of ploidy in DNA histograms is
internationally recognised (Hiddeman et al., 1984) methods
for measuring cell proliferation vary from centre to centre.
Such methods depend upon the fitting of mathematically
defined distributions to the experimental data and deriving
the area under each section of the histogram. These areas are
then expressed as a percentage of the total. Methods differ
principally in the type of distribution fitted to the S phase
fraction, whereas most assume a normal gaussian distribution
for GO/GI and G2/M phases (Baisch et al., 1982).
We have recently compared four different methods of
assessing cell proliferation in DNA histograms. Our test
material consisted of computer synthesised histograms and
histograms obtained from a series of formalin fixed, paraffin
embedded rectal carcinomas for which survival data was
available. Previous analysis of this series had demonstrated a
significant association between longer survival and low
growth fraction (Quirke et al., 1987).
The synthetic histograms were generated using an Easy 88
computer (Coulter Electronics, Hialeh, Florida, USA) with
CV's (coefficient of variation) ranging from 1 to 14. Fifty-six
histograms with seven different proliferative indices (S + G2/M
fraction) between 10 and 50% were synthesised in total. Each
histogram was measured using four different cell cycle
analysis programs and cell proliferation was expressed as
either the proliferative index (PI) or S phase fraction (Baisch
method). The four programs used differ in the type of distri-
bution fitted to S phase (Figure 1) and are all in routine use.
To express the difference between measured and actual cell
cycle distribution the relative deviation (RD) was calculated
(Baisch et al., 1982). RD represents the difference between
actual and estimated values as a percentage of the actual
value:
estimated phase fraction - actual phase fraction
RD =x10 actual phase fraction
x 100
In the second part of the study, DNA histograms from
forty-four diploid rectal cancers were selected from a larger
series (Quirke et al., 1987). DNA aneuploid tumours were
excluded in order to remove a further variable from the
analysis. Each case was measured once using the four
methods described above (mean CV = 7.8). One histogram
was measured per case, and Life Table analysis was per-
formed using the median P.I. or S phase fraction to divide
tumours into low and high proliferation groups. Median
follow-up for the series was 60 months, and the Log-rank
test was used to assess statistical significance. In order to
assess the reproducibility of measurements between different
observers 15 rectal cancer histograms ranging in CV from 4.1
to 9.3 were measured independently by two investigators
(N.S. and D.C.).
We found that whilst all four methods of cell cycle analysis
proved equally accurate in measuring the synthesised histo-
grams, with RDs generally less than 10% (Table I), there
were striking differences between the levels of cell prolifera-
tion recorded in the clinical series.
Median P.I. for the 44 tumours was 24.0% for Para 1;
8.25% for DNAfit and 9.7% for Sfit. Median S phase frac-
tion for the Baisch method was 8.4%. Reproducibility
between observers was good with correlation coefficients of
0.98 for Para 1; 0.97 for DNAfit; 0.62 for Sfit and 0.78 for
Baisch.
Para 1
S phase obtained by
subtraction.
nDNAfit
S phase represented by
multiple rectangles.
Sfit
S phase represented by
a second degree polynomial.
nBaisch a
S phase represented by
a single rectangle.
Figure 1 Four methods of cell cycle analysis.
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Table I Comparison of four cell cycle analysis programs
Compartment size
(Go/G,: S:G2M)
90:5:5 80:10:10 70:10:20 60:20:20 50:20:30
CV 46 >6 <6 >6 <6 >6 <6 >6 <6 >6
Para 1 2.4 9.1 2.4 9.4 2.7 8.4 3.3 10.1 3.1 7.5
DNAfit 8.3 13.8 4.9 5.5 2.7 2.9 2.9 3.5 1.7 2.9
Sfit 4.8 2.8 5.4 2.0 4.4 0.7 6.7 1.5 3.1 1.9
Baisch 11.0 34.5 7.8 7.5 7.3 9.3 3.6 10.0 7.0 3.6
n.b. Two sets of figures are given for each histogram. These represent the relative
deviation of the S + G2M fraction for histograms with CV <6 and CV >6.
Both Para 1 and DNAfit gave statistically significant sur-
vival curves (P <0.03) with longer survival in the low pro-
liferation tumour group (Figure 2), but neither the Baisch
method (P = 0.58) nor Sfit (P = 0.82) showed a significant
survival advantage for tumours with low proliferative frac-
tions.
DNA ploidy is now well established as a prognostic indi-
cator in large bowel cancer (Wolley et al., 1982; Armitage
1985; Quirke et al., 1987; Jass et al., 1989). However the
value of cell proliferation in predicting survival has been
investigated in relatively few studies (Meyer & Prioleau,
1981; Quirke et al., 1987; Schutte et al., 1987). Our investiga-
tion shows that inconsistencies between flow cytometric
studies might arise due to the use of different cell cycle
analysis programs to measure proliferation. These programs,
based on different mathematical assumptions about the dis-
tribution ofcells in the cell cycle, are known to underestimate
the S phase component, but are thought to show reasonable
accuracy in measuring computer simulated histograms and
histograms derived from cell culture systems (Baisch et al.,
1982). To our knowledge however no-one has compared
these methods in a clinical series where proliferation is
believed to be of prognostic value. Our study of 44 diploid
rectal carcinomas clearly shows that the type of program
used to measure proliferation has a considerable influence on
the observed relationship between patient survival and
tumour growth fraction. Whilst two methods yielded a statis-
tically significant relationship between P.I. and survival, the
other two failed to reach significance. The comparable per-
formance of these methods in measuring computer synthesised
histograms suggests that the differences observed in the
clinical series do not reflect operator error, but rather that
there exists subtle differences between synthesised and experi-
mentally derived histograms which lead to a greater variation
in values for cell proliferation as determined by different
analysis programs. This may partly explain the variable results
described for non-Hodgkin's lymphoma by several authors
(Bauer et al., 1986; McLaughlin et al., 1988; Wooldridge et
al., 1988; Cowan et al., 1989).
In conclusion therefore, while definitions of DNA ploidy
and DNA index are internationally recognised, less attention
has been paid to the comparison and standardisation of flow
cytometric measurements of cell proliferation. This small
study suggests that cell cycle analysis programs in current use
may yield very different results when assessing clinical
material. A larger study along the lines of the National
Cancer Institute's flow cytometry network project (Coon et
al., 1988; Coon et al., 1989) might help resolve this problem
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Figure 2 a, Survival and cell proliferation (Para 1). b, Survival
and cell proliferation (DNAfit).
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